14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SANG vs VERS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
VERS Captures Overall Composite Edge (48.3 HOLD vs 48.5 HOLD), While SANG Leads 5–0 on Growth & Valuation Pillars
VERS Overall Winner
6-Pillar Tally: SANG 5 – 0 VERS (1 Tie)
Matrix Metrics: SANG 8 – 0 VERS
As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. SANG trades at $4.71 (N/M Forward P/E, -6.8% operating margin) versus VERS at $71.45 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANG vs VERS. Trailing 12-month operating profitability (SANG -6.8% vs VERS N/A) and valuation multiples (SANG N/M vs VERS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
SANG Moat ProfileCyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $159.9M market capitalization and -6.8% operating margin.
OpEx & R&D Reinvestment77.1% of Rev ($154M)
90D Engineering Disclosures0 Published
VERS Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SANG vs VERS Key Questions & Quantitative Answers
As of Nov 16, 2026, VERS (VERS) captures the overall head-to-head institutional edge over Sangoma Technologies Corporation Common Shares (SANG) on higher Unified Composite conviction (48.3/100 HOLD vs. 48.5/100 HOLD) after splitting the core matrix 0–8 (led by composite factor balance), while SANG wins 5–0 across the 6-pillar growth and valuation breakdown. SANG trades at $4.71 (N/M Forward P/E, -6.8% operating margin) versus VERS at $71.45 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: VERS earns the overall head-to-head edge with a stronger Unified Composite Score (48.3/100 HOLD vs. SANG 48.5/100 HOLD) and 2.07β · 24% Vol risk profile, whereas SANG leads top-line expansion (-21.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
SANG leads the Growth & Scale pillar: SANG posts -21.2% YoY revenue growth and +0.0% YoY earnings growth on $200M TTM revenue (70.3% gross margin, -6.8% operating margin), compared with VERS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SANG generates $200M in USD-normalized revenue versus N/A for VERS. In operating R&D and SG&A reinvestment, SANG deploys 77.1% of Rev ($154M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VERS.
SANG screens cheaper on headline valuation multiples. SANG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (2.5% EBITDA margin), whereas VERS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SANG (-37.8% ROE) versus VERS (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SANG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 21% Vol realized risk). By comparison, VERS carries 57.2% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.07β · 24% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.